BioCentury
ARTICLE | Product Development

AML Takes ASH

ASH abstracts point to new targets for AML and CAR therapies

November 21, 2016 11:51 PM UTC

An analysis of the nearly 5,000 abstracts to be presented at the American Society of Hematology meeting shows research on acute myelogenous leukemia will dominate.

BioCentury analyzed more than 2,200 abstracts concerning clinical research, including studies of therapeutics and diagnostic or prognostic biomarkers...